Stay updated on Risankizumab Autoinjector Usability Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.

Latest updates to the Risankizumab Autoinjector Usability Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new consolidated Locations section lists study sites by state (Arizona, Arkansas, California, Connecticut, Florida, Kansas, Maryland, Michigan, Missouri, New Hampshire, North Carolina, Oregon, Pennsylvania, Texas, Washington, Wisconsin) and the revision is updated to v3.3.3.SummaryDifference2%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedRemoved the government funding and operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page layout and styling have been refreshed, while core study details such as eligibility criteria and locations remain unchanged.SummaryDifference0.4%

- Check91 days agoChange DetectedUpdated page with a new version (v3.2.0) and a government-operating-status notice; removed the previous version tag (v3.1.0).SummaryDifference3%

- Check98 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Risankizumab Autoinjector Usability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.